GENE ONLINE|News &
Opinion
Blog

Coronavirus
COVID-19: FDA Grants Emergency Use Authorization for Eli Lilly’s Antibody Combo Therapy
2021-02-10
South Africa Defers AstraZeneca Vaccinations as Vaccine Only Provides Minimal Protection against COVID-19 Variant
2021-02-09
COVID-19 News: Singapore, Korea, and China Accelerate Vaccine Approval, Indonesia Devises Detection Strategies
2021-02-06
Phase 3 Trial Results Grant New Validity to Controversial Sputnik V Vaccine
2021-02-04
Clover Biopharmaceuticals Chooses Dynavax over GSK for COVID-19 Vaccine Adjuvant
2021-02-04
Taiwan Identifies Five Potential COVID-19 Drugs from 3,000 Existing Medicines
2021-01-31
Johnson & Johnson’s COVID-19 Vaccine Draws Mixed Reactions as it Registers 66% Efficacy
2021-01-31
Novavax’s Protein Subunit Vaccine Shows 89.3% Efficacy in Phase 3 UK Trial
2021-01-29
Merck Withdraws from COVID-19 Vaccine Race Due to Sub-par Response
2021-01-25
Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center
2021-01-24
Lilly’s Antibody Treatment Prevents COVID-19 Spread at Nursing Home
2021-01-23
COVID-19: LumiraDx’s Antigen Test Gets Approved in Two More Countries
2021-01-22
COVID-19: Another Study Suggests Pfizer/BioNTech Vaccine is Capable of Neutralizing UK Variant
2021-01-20
Johnson & Johnson’s Single Dose COVID-19 Vaccine is Safe and Promising
2021-01-17
Battle Ground Brazil: What is the Country Doing to Curb Record COVID-19 Deaths?
2021-01-08
1 2 3 4 5 13
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top